Efficacy and safety of patritumab deruxtecan (HER3-DXd) in EGFR inhibitor-resistant, EGFR-mutated (EGFRm) non-small cell lung cancer (NSCLC).

被引：31
|
作者：
Janne, Pasi A.
Baik, Christina S.
Su, Wu-Chou
Johnson, Melissa Lynne
Hayashi, Hidetoshi
Nishio, Makoto
Kim, Dong-Wan
Koczywas, Marianna
Gold, Kathryn A.
Steuer, Conor Ernst
Murakami, Haruyasu
Yang, James Chih-Hsin
Kim, Sang-We
Vigliotti, Michele
Qi, Zhenhao
Qiu, Yang
Zhao, Lihui
Sternberg, David W.
Yu, Channing
Yu, Helena Alexandra
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Seattle Canc Care Alliance, Seattle, WA USA
[3] Natl Cheng Kung Univ Hosp, Tainan, Taiwan
[4] Tennessee Oncol PLLC, Sarah Cannon Res Inst, Nashville, TN USA
[5] Kindai Univ Hosp, Osaka, Japan
[6] Japanese Fdn Canc Res, Canc Inst Hosp, Tokyo, Japan
[7] Seoul Natl Univ Hosp, Seoul, South Korea
[8] City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USA
[9] Univ Calif San Diego, San Diego, CA 92103 USA
[10] Emory Univ Hosp, 1364 Clifton Rd NE, Atlanta, GA 30322 USA
[11] Shizuoka Canc Ctr, Shizuoka, Japan
[12] Natl Taiwan Univ, Canc Ctr, Taipei, Taiwan
[13] Univ Ulsan, Coll Med, Seoul, South Korea
[14] Daiichi Sankyo Inc, Basking Ridge, NJ USA
[15] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.9007
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9007
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Repeated biopsy for mutational analysis on EGFR-mutated non-small cell lung cancer (EGFR-NSCLC): Feasibility and safety
    Anguera, G.
    Riudavets, M.
    Torrego, A.
    Pajares, V.
    Gimenez, A.
    Lopez-Vilaro, L.
    Martinez, E.
    Trujillo-Reyes, J. C.
    Lerma, E.
    Majem, M.
    ANNALS OF ONCOLOGY, 2017, 28
  • [22] Plasma metabolite biomarkers for EGFR-mutated non-small cell lung cancer (NSCLC)
    Thamlikitkul, Lucksamon
    Manocheewa, Siriphan
    Limjiasahapong, Suphitcha
    Wanichthanarak, Kwanjeera
    Panya, Atikorn
    Poungvarin, Naravat
    Pomyen, Yotsawat
    Khoomrung, Sakda
    CANCER RESEARCH, 2024, 84 (06)
  • [23] Patritumab Deruxtecan Is Efficacious in EGFR-Mutant Non-Small Cell Lung Cancer
    Zhang, H.
    Yu, X.
    Ye, J.
    Li, H.
    Hu, J.
    Tan, Y.
    CANCER DISCOVERY, 2023, 13 (12) : 2501 - 2501
  • [24] Intracranial efficacy of HER3-DXd in patients with previously treated advanced EGFR-mutated NSCLC: Results from HERTHENA-Lung01
    Johnson, M. L.
    Janne, P. A.
    Goto, Y.
    Yoh, K.
    Lee, S-H.
    Paz-Ares, L.
    Besse, B.
    Novello, S.
    Hayashi, H.
    Kim, D-W.
    John, T.
    Kao, S. C-H.
    Felip, E.
    Yang, J. C-H.
    Reck, M.
    Dong, Q.
    Sporchia, A.
    Sternberg, D. W.
    Yu, H. A.
    ANNALS OF ONCOLOGY, 2023, 34
  • [25] Treatment strategy of EGFR-mutated non-small cell lung cancer
    Tanaka, Fumihiro
    Yoneda, Kazue
    Takenaka, Masaru
    Kuroda, Koji
    JOURNAL OF THORACIC DISEASE, 2022, 14 (03) : 602 - 606
  • [26] How to Treat EGFR-Mutated Non-Small Cell Lung Cancer
    Belani, Neel
    Liang, Katherine
    Fradley, Michael
    Judd, Julia
    Borghaei, Hossein
    JACC: CARDIOONCOLOGY, 2023, 5 (04): : 542 - 545
  • [27] Emerging drugs for EGFR-mutated non-small cell lung cancer
    Sukrithan, Vineeth
    Deng, Lei
    Barbar, Alexander
    Cheng, Haiying
    EXPERT OPINION ON EMERGING DRUGS, 2019, 24 (01) : 5 - 16
  • [28] Systemic treatment of EGFR-mutated non-small cell lung cancer
    Czyzykowski, Rafal L.
    Wrona, Ewa K.
    Talajko, Agata
    Hasinska, Aleksandra M.
    Potemski, Piotr J.
    ONCOLOGY IN CLINICAL PRACTICE, 2024,
  • [29] Estrogen Metabolism in Patients with EGFR-Mutated and ALK-Mutated Non-Small Cell Lung Cancer (NSCLC)
    Bodor, J. N.
    Treat, J.
    Krzizike, D. D.
    Zawislak, C. L.
    Vanderveer, L.
    Yulis, M.
    Chau, A.
    Ross, E. A.
    Andrews, A. J.
    Clapper, M. L.
    JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (02) : S18 - S19
  • [30] Sunvozertinib monotherapy in EGFR tyrosine kinase inhibitor-resistant non-small cell lung cancer with EGFR mutations
    Wang, Mengzhao
    Xu, Yan
    Huang, Wen-Tsung
    Su, Wu-Chou
    Gao, Bo
    Lee, Chee Khoon
    Fang, Jian
    Zhu, Xuehua
    Yang, Zhenfan
    Jaenne, Pasi A.
    Yang, James Chih-Hsin
    LUNG CANCER, 2025, 199
12345